Ultrasound-assisted low-density solvent dispersive liquid–liquid microextraction for the determination of 4 designer benzodiazepines in urine samples by gas chromatography–triple quadrupole mass spectrometry
- 1 May 2017
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B
- Vol. 1053, 9-15
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Detection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokineticsJournal of Mass Spectrometry, 2013
- Characterization of the designer benzodiazepine pyrazolam and its detectability in human serum and urineForensic Toxicology, 2013
- New challenges and innovation in forensic toxicology: Focus on the “New Psychoactive Substances”Journal of Chromatography A, 2013
- Phenazepam: The drug that came in from the coldJournal of Forensic and Legal Medicine, 2012
- Social, policy, and public health perspectives on new psychoactive substancesDrug Testing and Analysis, 2011
- Case report: Etizolam and its major metabolites in two unnatural death casesForensic Science International, 2008
- Validation of new methodsForensic Science International, 2007
- Determination of 14 benzodiazepines and hydroxy metabolites, zaleplon and zolpidem as tert-butyldimethylsilyl derivatives compared with other common silylating reagents in whole blood by gas chromatography–mass spectrometryJournal of Chromatography B, 2005
- Validated toxicological determination of 30 drugs of abuse as optimized derivatives in oral fluid by long column fast gas chromatography/electron impact mass spectrometryJournal of Mass Spectrometry, 2005
- Quinazolines and 1,4-Benzodiazepines. VI.1a Halo-, Methyl-, and Methoxy-substituted 1,3-Dihydro-5-phenyl-2H-1,4-benzodiazepin-2-ones1b,cThe Journal of Organic Chemistry, 1962